IL139790A0 - Polymorphic form of clopidogrel hydrogen sulphate - Google Patents

Polymorphic form of clopidogrel hydrogen sulphate

Info

Publication number
IL139790A0
IL139790A0 IL13979099A IL13979099A IL139790A0 IL 139790 A0 IL139790 A0 IL 139790A0 IL 13979099 A IL13979099 A IL 13979099A IL 13979099 A IL13979099 A IL 13979099A IL 139790 A0 IL139790 A0 IL 139790A0
Authority
IL
Israel
Prior art keywords
polymorphic form
hydrogen sulphate
clopidogrel hydrogen
clopidogrel
sulphate
Prior art date
Application number
IL13979099A
Other languages
English (en)
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9527349&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL139790(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of IL139790A0 publication Critical patent/IL139790A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C30—CRYSTAL GROWTH
    • C30B—SINGLE-CRYSTAL GROWTH; UNIDIRECTIONAL SOLIDIFICATION OF EUTECTIC MATERIAL OR UNIDIRECTIONAL DEMIXING OF EUTECTOID MATERIAL; REFINING BY ZONE-MELTING OF MATERIAL; PRODUCTION OF A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; SINGLE CRYSTALS OR HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; AFTER-TREATMENT OF SINGLE CRYSTALS OR A HOMOGENEOUS POLYCRYSTALLINE MATERIAL WITH DEFINED STRUCTURE; APPARATUS THEREFOR
    • C30B7/00—Single-crystal growth from solutions using solvents which are liquid at normal temperature, e.g. aqueous solutions

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IL13979099A 1998-06-15 1999-06-10 Polymorphic form of clopidogrel hydrogen sulphate IL139790A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9807464A FR2779726B1 (fr) 1998-06-15 1998-06-15 Forme polymorphe de l'hydrogenosulfate de clopidogrel
PCT/FR1999/001371 WO1999065915A1 (fr) 1998-06-15 1999-06-10 Forme polymorphe de l'hydrogenosulfate de clopidogrel

Publications (1)

Publication Number Publication Date
IL139790A0 true IL139790A0 (en) 2002-02-10

Family

ID=9527349

Family Applications (2)

Application Number Title Priority Date Filing Date
IL13979099A IL139790A0 (en) 1998-06-15 1999-06-10 Polymorphic form of clopidogrel hydrogen sulphate
IL139790A IL139790A (en) 1998-06-15 2000-11-20 A polymorphic form of clopidogrel hydrogen sulfate

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL139790A IL139790A (en) 1998-06-15 2000-11-20 A polymorphic form of clopidogrel hydrogen sulfate

Country Status (44)

Country Link
US (2) US6429210B1 (xx)
EP (1) EP1087976B1 (xx)
JP (1) JP3641584B2 (xx)
KR (1) KR100511238B1 (xx)
CN (1) CN1128805C (xx)
AP (1) AP1344A (xx)
AR (1) AR014854A1 (xx)
AT (1) ATE222256T1 (xx)
AU (1) AU752170B2 (xx)
BG (1) BG64508B1 (xx)
BR (1) BR9911219A (xx)
CA (1) CA2334870C (xx)
CO (1) CO5040084A1 (xx)
CZ (1) CZ299654B6 (xx)
DE (1) DE69902536T2 (xx)
DK (1) DK1087976T3 (xx)
DZ (1) DZ2817A1 (xx)
EA (1) EA002386B1 (xx)
EE (1) EE03972B1 (xx)
EG (1) EG24015A (xx)
ES (1) ES2181439T3 (xx)
FR (1) FR2779726B1 (xx)
HK (1) HK1033829A1 (xx)
HR (1) HRP20000863B1 (xx)
HU (1) HU225871B1 (xx)
ID (1) ID28264A (xx)
IL (2) IL139790A0 (xx)
IS (1) IS2469B (xx)
ME (1) ME00686B (xx)
MY (1) MY129439A (xx)
NO (1) NO327161B1 (xx)
NZ (1) NZ507914A (xx)
OA (1) OA11567A (xx)
PL (1) PL201894B1 (xx)
PT (1) PT1087976E (xx)
RS (1) RS49870B (xx)
SA (1) SA99200321B1 (xx)
SK (1) SK286340B6 (xx)
TR (1) TR200003417T2 (xx)
TW (1) TW562805B (xx)
UA (1) UA70323C2 (xx)
UY (1) UY25693A1 (xx)
WO (1) WO1999065915A1 (xx)
ZA (1) ZA200006386B (xx)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2792836B3 (fr) 1999-04-30 2001-07-27 Sanofi Sa Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel
CA2363053C (en) * 2001-11-09 2011-01-25 Bernard Charles Sherman Clopidogrel bisulfate tablet formulation
PT1467735E (pt) * 2001-12-18 2009-03-10 Teva Pharma Polimorfos de hidrogenossulfato de clopidogrel
US6767913B2 (en) * 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
HUP0200438A3 (en) * 2002-02-06 2003-10-28 Egis Gyogyszergyar Nyilvanosan Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them
AU2003221932B2 (en) 2002-04-16 2007-11-22 Merck Sharp & Dohme Corp. Tricyclic thrombin receptor antagonists
JP2005529933A (ja) * 2002-05-31 2005-10-06 シェーリング　コーポレイション キサンチンホスホジエステラーゼｖインヒビター多形体
US6800759B2 (en) * 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
CZ297472B6 (cs) * 2002-08-27 2006-12-13 Zentiva, A.S. Zpusob výroby clopidogrelu hydrogensulfátu krystalické formy I
US20040067995A1 (en) * 2002-10-02 2004-04-08 Wong Pancras C. Novel combination of a factor Xa inhibitor and clopidogrel
ITMI20022228A1 (it) * 2002-10-21 2004-04-22 Dinamite Dipharma S P A Sali di clopidogrel con acidi alchil-solforici.
AU2003285841A1 (en) * 2002-11-28 2004-06-18 Anpharm Przedsiebiorstwo Farmaceutyczne S.A. A process for the preparation of crystalline form 1 or clopidogrel hydrogen sulfate
DE10307343B4 (de) * 2003-02-21 2005-10-06 Volkswagen Ag On-Board-Diagnosevorrichtung und On-Board-Diagnoseverfahren für Kraftfahrzeuge
WO2004081015A1 (en) * 2003-03-10 2004-09-23 Hetero Drugs Limited Amorphous clopidogrel hydrogen sulfate
WO2004081016A1 (en) 2003-03-12 2004-09-23 Cadila Healthcare Limited Polymorphs and amorphous form of (s) - (+) -clopidogrel bisulfate
EP1618111B1 (en) * 2003-04-25 2014-12-24 Cadila Healthcare Limited Salts of clopidogrel and process for preparation
CA2530446A1 (en) 2003-07-02 2005-01-13 Egis Gyogyszergyar Rt. Process for the preparation of amorphous form of a platelet aggregation inhibitor drug
WO2005003139A1 (en) * 2003-07-02 2005-01-13 EGIS Gyógyszergyár Rt. Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drug
ATE557028T1 (de) * 2003-08-04 2012-05-15 Wockhardt Ltd Neues verfahren zur herstellung von (+)-(s)- clopidogrelbisulfat form-i
DE10337773A1 (de) * 2003-08-13 2005-03-24 Krka Tovarna Zdravil, D.D. Kristallisation von festen Formen von Clopidogrel-Additionssalzen
GB0321256D0 (en) * 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
CA2544443C (en) 2003-11-03 2010-08-17 Cadila Healthcare Limited Processes for preparing different forms of (s)-(+)-clopidogrel bisulfate
CA2457459A1 (en) * 2004-02-11 2005-08-11 Brantford Chemicals Inc. Resolution of racemates of methyl alpha-5-(4,5,6,7-tetrahydro(3,2-c)thienopyridyl)-(2-chlorophenyl) acetate
US20070249660A1 (en) * 2004-02-24 2007-10-25 Weber Beat T Pharmacologically Acceptable Salts of Clopidogrel
US7629465B2 (en) * 2004-03-05 2009-12-08 Ipca Laboratories Ltd. Industrial process for preparation of Clopidogrel hydrogen sulphate
EP1732932B1 (en) * 2004-04-09 2012-03-21 Hanmi Holdings Co., Ltd. Crystalline clopidogrel naphthalenesulfonate or hydrate thereof, method for preparing same and pharmaceutical composition containing same
HUE029459T2 (en) * 2004-04-19 2017-02-28 Krka Tovarna Zdravil D D Novo Mesto Methods for the Preparation of Polymorph Form I of Clopidogrel Hydrogen Sulphate
NZ551374A (en) * 2004-04-20 2010-08-27 Sanofi Aventis Clopidogrel naphthalenedisulfonate salt and polymorphic forms thereof
WO2005103058A1 (en) * 2004-04-20 2005-11-03 Sanofi-Aventis Polymorphic forms of methyl (+) - (s) -alpha- (2-chlorophenyl) -6, 7-dihydrothieno `3,2-c!pyridine-584h) acetate hydrobromide, clopidrogel hydrobromide
US7829720B2 (en) 2004-05-04 2010-11-09 Bristol-Myers Squibb Company Process for preparing atazanavir bisulfate and novel forms
JP2007513889A (ja) * 2004-09-21 2007-05-31 テバ ファーマシューティカル インダストリーズ リミティド 結晶性クロピドグレル臭酸塩及びその調製方法
US7446200B2 (en) * 2004-10-04 2008-11-04 Usv, Ltd. Rapid resolution process of clopidogrel base and a process for preparation of clopidogrel bisulfate polymorph-form I
CA2567806C (en) * 2005-02-15 2011-04-26 Usv Limited Rapid resolution process of clopidogrel base and a process for preparation of clopidogrel bisulfate polymorph - form i
EP1693375A1 (en) * 2005-02-21 2006-08-23 KRKA, tovarna zdravil, d.d., Novo mesto Process for preparing clopidrogel hydrogen sulfate of form I
WO2006091847A2 (en) * 2005-02-24 2006-08-31 Teva Pharmaceutical Industries Ltd. Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
US7772398B2 (en) * 2005-03-11 2010-08-10 Dr. Reddy's Laboratories, Inc. Process for making crystalline form I of clopidogrel hydrogen sulphate
CN101212954A (zh) * 2005-05-10 2008-07-02 伊兰制药国际有限公司 纳米粒氯吡格雷制剂
KR20080016952A (ko) * 2005-06-13 2008-02-22 엘란 파마 인터내셔널 리미티드 나노입자형 클로피도그렐과 아스피린의 배합 제제
KR20070009851A (ko) * 2005-07-14 2007-01-19 씨제이 주식회사 클로피도그렐 황산수소염 함유 약학 조성물
EP1934229B1 (en) 2005-09-05 2012-09-26 Cadila Healthcare Limited Processes for the preparation of different forms of (s)-(+)-clopidogrel besylate
KR100736024B1 (ko) * 2005-09-21 2007-07-06 주식회사종근당 신규한 클로피도그렐 우선성 광학이성체의 이온교환수지착체와 그 제조방법
WO2007091253A2 (en) * 2006-02-06 2007-08-16 C.T.S. Ltd. Pharmaceutical compositions comprising clopidogrel and vitamins which reduce homocysteine levels
US20070225320A1 (en) * 2006-03-27 2007-09-27 Eswaraiah Sajja Process for preparing clopidogrel
EP2001449A2 (en) * 2006-04-05 2008-12-17 Cadila Healthcare Ltd. Modified release clopidogrel formulation
RU2008146758A (ru) * 2006-04-27 2010-06-10 Инд-Свифт Лэборетриз Лимитед (In) Способ получения полиморфных форм клопидогрела гидросульфата
JP2009539846A (ja) * 2006-06-06 2009-11-19 ブリストル−ミエルス スクイッブ カンパニー Ｎ−［５−［［［５−（１，１−ジメチルエチル）−２−オキサゾリル］メチル］チオ］−２−チアゾリル］−４−ピペリジンカルボキサミドの結晶形
CA2655844A1 (en) * 2006-08-03 2008-02-14 Teva Pharmaceutical Industries Ltd. Process for preparing clopidogrel bisulphate
DK2064217T3 (da) * 2006-09-04 2011-05-09 Ranbaxy Lab Ltd Forbedret fremgangsmåde til fremstilling af clopidogrel og dets farmaceutisk acceptable salte
SI22383A (sl) * 2006-09-22 2008-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze klopidogrela in nove oblike njegovih farmacevtsko sprejemljivih soli
US20100062066A1 (en) * 2006-11-14 2010-03-11 Acusphere, Inc Formulations of Tetrahydropyridine Antiplatelet Agents for Parenteral or Oral Administration
KR20080055356A (ko) * 2006-12-15 2008-06-19 에스케이케미칼주식회사 보관안정성이 우수한 클로피도그렐 함유 포접 복합체
CA2673228A1 (en) * 2006-12-22 2008-07-03 Schering Corporation Disintegration promoters in solid dose wet granulation formulations
EP2114957A4 (en) * 2007-01-29 2011-06-08 Ipca Lab Ltd PROCESS FOR THE PREPARATION OF A CRYSTALLINE FORM 1 OF A CLOPIDOGREL HYDROGEN SULFATE
EP1970054A3 (en) 2007-03-14 2009-06-03 Ranbaxy Laboratories Limited Clopidogrel tablets
PL382055A1 (pl) * 2007-03-23 2008-09-29 Koźluk Tomasz Nobilus Ent Sposób wytwarzania formy krystalicznej 1 wodorosiarczanu klopidogrelu
KR20160033792A (ko) 2007-04-27 2016-03-28 사이덱스 파마슈티칼스, 인크. 클로피도그렐 및 설포알킬 에테르 사이클로덱스트린을 함유하는 제형 및 사용 방법
WO2009080469A1 (en) * 2007-12-24 2009-07-02 Sandoz Ag Process for the preparation of clopidogrel bisulphate form i
ATE530172T1 (de) * 2008-02-26 2011-11-15 Lesvi Laboratorios Sl Pharmazeutische formulierungen mit clopidogrel
EP2107061A1 (en) 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
US20090264460A1 (en) * 2008-04-21 2009-10-22 Mamta Mishra Clopidogrel pharmaceutical formulations
US20120121706A1 (en) 2009-04-10 2012-05-17 Tufts Medical Center, Inc. PAR-1 Activation by Metalloproteinase-1 (MMP-1)
ES2769949T3 (es) 2009-05-13 2020-06-29 Cydex Pharmaceuticals Inc Composiciones farmacéuticas que comprenden prasugrel y derivados de ciclodextrina y métodos de preparación y uso de las mismas
WO2011010318A1 (en) * 2009-07-23 2011-01-27 Praveen Laboratories Private Limited Process for the preparation of clopidogrel polymorphous form 1 using seed chrystals
WO2011042804A2 (en) 2009-10-08 2011-04-14 Jubliant Life Sciences Limited An improved process for the preparation of clopidogrel hydrogen sulfate form i
KR101130445B1 (ko) * 2009-10-29 2012-03-27 동아제약주식회사 클로피도그랠 황산수소염 ⅰ형 제조방법
WO2011051976A2 (en) 2009-10-30 2011-05-05 Matrix Laboratories Ltd An improved process for the preparation of clopidogrel bisulfate form i
CN101766573B (zh) 2010-02-05 2013-02-13 上海安必生制药技术有限公司 硫酸氢氯吡格雷固体制剂的制备工艺
WO2011125069A1 (en) 2010-03-22 2011-10-13 Rpg Life Sciences Limited A process for preparation of crystalline form i of clopidogrel bisulfate
WO2011132201A1 (en) 2010-04-19 2011-10-27 Cadila Healthcare Limited A pharmaceutical composition comprising antiplatelet agents and an erythropoiesis stimulating agent
JP2014518260A (ja) 2011-06-27 2014-07-28 アイピーシーエー ラボラトリーズ リミテッド 抗血栓症化合物
KR101324862B1 (ko) * 2011-07-12 2013-11-01 (주)에이에스텍 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법
CN102367257B (zh) * 2011-11-21 2014-05-07 天津红日药业股份有限公司 氯吡格雷盐酸盐的单晶晶型，它们的制备及应用
WO2014118802A1 (en) 2013-01-31 2014-08-07 Pharmazell Gmbh An improved process for the preparation of clopidogrel bisulfate form-i
JP5905165B2 (ja) 2013-08-02 2016-04-20 サノフイ アセチルサリチル酸およびクロピドグレルを含む医薬錠剤
CN103524528A (zh) * 2013-09-16 2014-01-22 吉林省博大伟业制药有限公司 一种改进的ⅱ型硫酸氢氯吡格雷结晶制备方法
HUP1400294A2 (hu) 2014-06-13 2015-12-28 Skillpharm Kft Clopidogrel új alkalmazása
KR101710922B1 (ko) 2015-06-03 2017-02-28 경동제약 주식회사 클로피도그렐 황산염 결정형 i형의 제조방법
CN107698620A (zh) 2015-06-23 2018-02-16 江苏天士力帝益药业有限公司 一种氘代噻吩并哌啶衍生物、制备方法及其应用
CN110198705A (zh) 2017-01-23 2019-09-03 同和药品株式会社 包含hmg-coa还原酶抑制剂和氯吡格雷的复合制剂
CN107163060B (zh) * 2017-05-24 2021-03-02 常州制药厂有限公司 一种硫酸氢氯吡格雷晶型ii制备方法
CN107337683B (zh) * 2017-08-16 2019-08-16 中荣凯特（北京）生物科技有限公司 一种噻吩并吡啶类衍生物硫酸氢盐的晶型ⅱ及其制备方法和应用
CN109438467B (zh) * 2018-11-14 2021-03-26 四川青木制药有限公司 一种硫酸氢氯吡格雷ⅱ型球形结晶的制备方法
WO2023012479A1 (en) 2021-08-03 2023-02-09 Liqmeds Worldwide Limited An oral pharmaceutical solution of clopidogrel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2664276B1 (fr) 1990-07-04 1992-10-23 Sanofi Sa Derive thienyl-2 glycidique, son procede de preparation et son utilisation comme intermediaire de synthese.

Also Published As

Publication number Publication date
OA11567A (en) 2004-05-24
TR200003417T2 (tr) 2001-03-21
HRP20000863B1 (en) 2003-04-30
WO1999065915A1 (fr) 1999-12-23
HUP0104343A2 (hu) 2002-03-28
SK286340B6 (en) 2008-07-07
SA99200321B1 (ar) 2006-10-11
AP2000001979A0 (en) 2000-12-31
IL139790A (en) 2006-10-05
CZ20004637A3 (cs) 2001-04-11
ES2181439T3 (es) 2003-02-16
ZA200006386B (en) 2001-05-07
NO327161B1 (no) 2009-05-04
EG24015A (en) 2008-03-24
DZ2817A1 (fr) 2004-06-02
CA2334870C (en) 2005-03-15
NZ507914A (en) 2002-11-26
CA2334870A1 (en) 1999-12-23
KR20010052835A (ko) 2001-06-25
KR100511238B1 (ko) 2005-08-31
PL201894B1 (pl) 2009-05-29
NO20006395L (no) 2001-02-15
UA70323C2 (uk) 2004-10-15
DE69902536D1 (en) 2002-09-19
EA200001187A1 (ru) 2001-08-27
HRP20000863A2 (en) 2001-10-31
AU752170B2 (en) 2002-09-05
TW562805B (en) 2003-11-21
CO5040084A1 (es) 2001-05-29
FR2779726A1 (fr) 1999-12-17
DE69902536T2 (de) 2003-03-13
PL344998A1 (en) 2001-11-19
SK19092000A3 (sk) 2001-05-10
BR9911219A (pt) 2001-03-06
RS49870B (sr) 2008-08-07
PT1087976E (pt) 2002-11-29
ATE222256T1 (de) 2002-08-15
EP1087976B1 (fr) 2002-08-14
US6504030B1 (en) 2003-01-07
BG104987A (en) 2001-11-30
IS2469B (is) 2008-12-15
NO20006395D0 (no) 2000-12-14
DK1087976T3 (da) 2002-12-02
UY25693A1 (es) 2000-03-31
CN1128805C (zh) 2003-11-26
IS5716A (is) 2000-11-17
CN1305483A (zh) 2001-07-25
HU225871B1 (en) 2007-11-28
AU4048399A (en) 2000-01-05
EE200000745A (et) 2002-04-15
EE03972B1 (et) 2003-02-17
JP3641584B2 (ja) 2005-04-20
YU77700A (sh) 2003-04-30
JP2002518399A (ja) 2002-06-25
HUP0104343A3 (en) 2003-03-28
BG64508B1 (bg) 2005-05-31
EP1087976A1 (fr) 2001-04-04
ME00686B (me) 2008-08-07
AR014854A1 (es) 2001-04-11
ID28264A (id) 2001-05-10
EA002386B1 (ru) 2002-04-25
MY129439A (en) 2007-04-30
US20020198229A1 (en) 2002-12-26
CZ299654B6 (cs) 2008-10-08
HK1033829A1 (en) 2001-09-28
FR2779726B1 (fr) 2001-05-18
US6429210B1 (en) 2002-08-06
AP1344A (en) 2004-12-15

Similar Documents

Publication Publication Date Title
IL139790A0 (en) Polymorphic form of clopidogrel hydrogen sulphate
GB9912155D0 (en) Methods of trating preform elements
PL346544A1 (en) Crystalline forms of eto2
GB9800855D0 (en) Production of alumina
PL342733A1 (en) Biocement of improved properties
GB9805417D0 (en) Production of microparticles
EP1079861A4 (en) REGULATION OF BIOFILM EDUCATION
HU9902783D0 (en) Polymorph of zopolrestat monohydrate
IL124920A0 (en) Manufacture of boxes
HUP0202614A3 (en) Use of thienopyrimidines
TW475509U (en) Structure of tool set
TW386595U (en) Waterproof structure of waterproof lamp
TW354110U (en) Improvement of padlock
TW437295U (en) Structure of waterproof combined shoes-and-pant
TW405677U (en) Improvement of up/down structure
GB9912069D0 (en) Production of hydrogen
GB2354514B (en) Stabilizing of iron sulphate
TW371034U (en) Improved structure of candlestick
TW420233U (en) Improved structure of padlock
GB9819963D0 (en) Method of selecting cells
TW350403U (en) Improvement of decoration
TW398215U (en) Structure of dual-purpose water pot
TW398188U (en) Improved structure of de-hooker
HU9800243D0 (en) Insulation of watch-case
TW364693U (en) Inside structure of plug